Your browser doesn't support javascript.
loading
Optimizing Postneoadjuvant Treatment in Patients With Early Breast Cancer Achieving Pathologic Complete Response.
Valenza, Carmine; Trapani, Dario; Loibl, Sibylle; Chia, Stephen K L; Burstein, Harold J; Curigliano, Giuseppe.
Afiliación
  • Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Trapani D; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Loibl S; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
  • Chia SKL; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Burstein HJ; Center for Hematology and Oncology Bethanien, Frankfurt, Germany.
  • Curigliano G; BC Cancer Agency, Vancouver, BC, Canada.
J Clin Oncol ; 42(20): 2372-2376, 2024 Jul 10.
Article en En | MEDLINE | ID: mdl-38569132
ABSTRACT
pCR should be integrated with other prognostic factors to optimize postneoadjuvant treatments in BC.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Límite: Female / Humans Idioma: En Revista: J Clin Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Límite: Female / Humans Idioma: En Revista: J Clin Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia